BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29187174)

  • 21. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
    Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
    J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer.
    Svedlund J; Strell C; Qian X; Zilkens KJC; Tobin NP; Bergh J; Sieuwerts AM; Nilsson M
    EBioMedicine; 2019 Oct; 48():212-223. PubMed ID: 31526717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumoral heterogeneity of breast cancer.
    Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
    Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
    Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
    Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
    Tishchenko I; Milioli HH; Riveros C; Moscato P
    PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current possibilities of clinical applications of breast tumors typing expression].
    Moiseenko FV; Volkov NM; Bogdanov AA; Semiglazov VF; Dubina MV
    Vopr Onkol; 2016; 62(1):31-4. PubMed ID: 30444329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular signatures in breast cancer.
    Lal S; McCart Reed AE; de Luca XM; Simpson PT
    Methods; 2017 Dec; 131():135-146. PubMed ID: 28669865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast Molecular Profiling and Radiotherapy Considerations.
    Mahmoud O; Haffty BG
    Adv Exp Med Biol; 2016; 882():95-124. PubMed ID: 26987532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
    Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
    Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the intrinsic differences among breast tumor subtypes defined using immunohistochemistry markers based on the decision tree.
    Li Y; Tang XQ; Bai Z; Dai X
    Sci Rep; 2016 Oct; 6():35773. PubMed ID: 27786176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-Low Breast Cancer; Clinical & Pathological Characteristics.
    Dias K; Dvorkin-Gheva A; Hallett RM; Wu Y; Hassell J; Pond GR; Levine M; Whelan T; Bane AL
    PLoS One; 2017; 12(1):e0168669. PubMed ID: 28045912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
    Wei L; Wang J; Lampert E; Schlanger S; DePriest AD; Hu Q; Gomez EC; Murakam M; Glenn ST; Conroy J; Morrison C; Azabdaftari G; Mohler JL; Liu S; Heemers HV
    Eur Urol; 2017 Feb; 71(2):183-192. PubMed ID: 27451135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
    Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
    Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
    Eilertsen IA; Moosavi SH; Strømme JM; Nesbakken A; Johannessen B; Lothe RA; Sveen A
    Cancer Lett; 2020 Jan; 469():246-255. PubMed ID: 31678167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
    Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
    Wang K; Duan X; Gao F; Wang W; Liu L; Wang X
    PLoS One; 2018; 13(9):e0203824. PubMed ID: 30216380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.